Search - tctmd.com

Displaying 981 - 1000 of 1554

Sort: Relevancy | Date

Presentation TCT 2017

Representation of Women and Minorities in European Trials

Presenter: David P. Faxon, Cindy L. Grines, Angeles Alonso Garcia

October 31, 2017

Presentation TCT 2017

Debate: ABSORB Is Likely Finished - The Limitation of the Technology Can Not Be Overcome

Presenter: Stephen G. Ellis, Takeshi Kimura, Robert A. Byrne

October 31, 2017

Presentation TCT 2017

The Potential For BRS: What Weve Learned From Pushing The Envelope

Presenter: Stephen G. Ellis, Takeshi Kimura, Corrado Tamburino

October 31, 2017

Presentation TCT 2017

Strategies to Increase Enrollment of Women and Minorities Into Clinical Trials

Presenter: David P. Faxon, Cindy L. Grines, Roxana Mehran

October 31, 2017

Presentation TCT 2017

Buma Stent: Device Specifications, Clinical Trial Results, and Global Development

Presenter: Manel Sabate, Joanna J. Wykrzykowska, Kefei Dou

October 31, 2017

Presentation TCT 2017

Registry Update: ABSORB SCAAR

Presenter: Stephen G. Ellis, Takeshi Kimura, Stefan K. James

October 31, 2017

Presentation TCT 2017

Registry Update: BVS STEMI STRATEGY

Presenter: Stephen G. Ellis, Takeshi Kimura, Alfonso Ielasi

October 31, 2017

Presentation TCT 2017

Registry Update: IT-DISAPPEARS

Presenter: Stephen G. Ellis, Takeshi Kimura, Francesco Bedogni

October 31, 2017

Presentation TCT 2017

FDA Perspectives on Diversity in Clinical Trials

Presenter: David P. Faxon, Cindy L. Grines, Christopher J Popma

October 31, 2017

Presentation TCT 2017

Musings on TMVR Patient Selection Criteria to Date, and Which Patients Should Be Put in TMVR Trials Rather Than Treated Clinically With Current Devices

Presenter: Howard C. Herrmann, Michael J. Mack

October 31, 2017

Presentation TCT 2017

Registry Update: FRANCE ABSORB

Presenter: Stephen G. Ellis, Takeshi Kimura, Didier Carrié

October 31, 2017

Presentation TCT 2017

Registry Update: GABI-R

Presenter: Stephen G. Ellis, Takeshi Kimura, Holger M. Nef

October 31, 2017

Presentation TCT 2017

Registry Update: ABSORB UK

Presenter: Stephen G. Ellis, Takeshi Kimura, Mark A. de Belder

October 31, 2017

Presentation TCT 2017

Registry Update: ABSORB Extend At 3 Years

Presenter: Stephen G. Ellis, Takeshi Kimura, Antonio L. Bartorelli

October 31, 2017

Presentation TCT 2017

What Is the Optimal DAPT Duration With ABSORB? Results From a Comprehensive Meta-Analysis

Presenter: Azeem Latib, Gregg W. Stone

October 31, 2017

Presentation TCT 2017

ABSORB IV 30-Day Results: Is Improved Technique Reflected in Superior Early Outcomes?

Presenter: Azeem Latib, Dean J. Kereiakes

October 31, 2017

Presentation TCT 2017

Featured Lecture: ABSORB Program 3-Year Meta-Analysis and Adjusted PSP Evaluation - Lessons Learned With a First Generation Scaffold

Presenter: Azeem Latib, Gregg W. Stone

October 31, 2017

Presentation TCT 2017

ABSORB II at 4 Years: Clinical Outcomes Beyond the Cusp of Complete Bioresorption

Presenter: Azeem Latib, Bernard R. Chevalier

October 31, 2017

Presentation TCT 2017

Outcomes and Clinical Implications From the Euro-CTO Trial

Presenter: Barry D. Rutherford, Robert W. Yeh, Gerald S. Werner

October 31, 2017

Presentation TCT 2017

ABSORB in STEMI I: TROFI II 3-Year Clinical Outcomes and Correlations With the 6-Month OCT Findings

Presenter: Azeem Latib, Manel Sabate

October 31, 2017

Advertisement

Representation of Women and Minorities in European Trials

Debate: ABSORB Is Likely Finished - The Limitation of the Technology Can Not Be Overcome

The Potential For BRS: What Weve Learned From Pushing The Envelope

Strategies to Increase Enrollment of Women and Minorities Into Clinical Trials

Buma Stent: Device Specifications, Clinical Trial Results, and Global Development

Registry Update: ABSORB SCAAR

Registry Update: BVS STEMI STRATEGY

Registry Update: IT-DISAPPEARS

FDA Perspectives on Diversity in Clinical Trials

Musings on TMVR Patient Selection Criteria to Date, and Which Patients Should Be Put in TMVR Trials Rather Than Treated Clinically With Current Devices

Registry Update: FRANCE ABSORB

Registry Update: GABI-R

Registry Update: ABSORB UK

Registry Update: ABSORB Extend At 3 Years

What Is the Optimal DAPT Duration With ABSORB? Results From a Comprehensive Meta-Analysis

ABSORB IV 30-Day Results: Is Improved Technique Reflected in Superior Early Outcomes?

Featured Lecture: ABSORB Program 3-Year Meta-Analysis and Adjusted PSP Evaluation - Lessons Learned With a First Generation Scaffold

ABSORB II at 4 Years: Clinical Outcomes Beyond the Cusp of Complete Bioresorption

Outcomes and Clinical Implications From the Euro-CTO Trial

ABSORB in STEMI I: TROFI II 3-Year Clinical Outcomes and Correlations With the 6-Month OCT Findings

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content